Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

NCT00373347 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT00373347
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00373347 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma
Lead sponsor
Stanford University
Phase
Observational
Overall status
Completed
Start date
November 30, 2004
Completion date
November 18, 2024
Enrollment
573 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver cancer